This discrepancy could be explained by the fact that Black individuals more often have smaller apo(a) isoforms, so mass-based assays (mg/dL) can obscure particle-level risk, and by a greater burden of cardiovascular risk factors in Black populations, particularly hypertension, which contributes to premature events.18 The gene discussed is LPA; the disease is Hypertension.